ESC Premium Access

A view to the future: approach to vulnerable plaque and/or vulnerable patients


About the speaker

Professor Robert Byrne

Mater Private Hospital, Dublin (Ireland)
14 presentations
1 follower

1 more presentation in this session

Efficacy and safety of inclisiran in patients with polyvascular disease: pooled, post hoc analysis of the ORION-9, ORION-10 and ORION-11, phase 3 randomised controlled trials

Speaker: Professor W. Koenig (Munich, DE)


Access the full session

Evolving frontiers for coronary artery disease

Speakers: Professor R. Byrne, Professor W. Koenig

About the event


ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

The 12-Lead ECG as a biomarker of physiologic age

22 October 2021

ESC Premium Access

The long non-coding RNA Heat4 is upregulated in heart failure and decreases the immune response of non-classical monocytes

27 August 2021

ESC Premium Access

The novel ageing-induced long non-coding RNA MIRIAL controls endothelial cell and mitochondrial function

27 August 2021

This platform is supported by

logo Novo Nordisk